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Abstract 
BACKGROUND:  With the epidemic of diabetes mellitus projected to rise from 1 in 10 U.S. 
adults (year 2010) to 1 in 3 by the year 2050, there is a need for health care organizations to 
prepare nurses to manage the complexity of meeting the needs of patients with diabetes, 
especially in the timely administration of subcutaneous insulin.   The traditionally accepted 
practice of double-checking subcutaneous insulin before administration, albeit non-evidence-
based, poses a clinical problem by imposing an unnecessary demand on nurses’ workload, which 
places an obstacle to their timely administration of time-critical subcutaneous insulin.  
PURPOSE:  This project aimed to examine if there would be a difference in medication errors 
surrounding nurses’ subcutaneous insulin administration when their system is altered from an 
independent double-checking to a single-checking environment.  METHODS:  This quasi-
experimental project was composed of a two-phase pilot study, with the first (double-checking) 
acting as the control and the second (single-checking) acting as the interventional phase.  
RESULTS:  Over a seven-week period, there were a total of 1,528 opportunities for 
subcutaneous insulin administration and omission in both phases among the 92 patients included 
in the sample.  There was no significant difference in the “any one error” rates between the 
double-checking and single-checking phases.  Of administration error types, “wrong-time” was 
predominant and more prevalent during the double-checking phase, which took an average of 
11.7 minutes longer.  CONCLUSIONS:  The traditional double-checking process did not 
significantly reduce medication error rates and contributed to a longer time lapse from blood 
glucose check to insulin administration.   
 Keywords: double-checking, subcutaneous insulin, medication errors, high-reliability 
organizations
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Chapter 1 
 Introduction 
The Institute for Safe Medication Practices (ISMP), a non-profit organization dedicated 
to eradicate medication errors by educating practitioners and consumers about safe medication 
practices, conducted a study from 1995 to 1996 that identified insulin as one of the “top five” 
high-alert medications (Cohen, Proulx, & Crawford, 1998).  High-alert medications (HAMs) are 
drugs that carry the highest risk of causing serious patient injury when misused (Cohen & 
American Pharmaceutical Association [APhA], 1999).  In 1999, The Joint Commission (TJC) 
issued an alert that cited the study’s top five “high-alert medications” and listed common risk 
factors that contributed to related medication errors (The Joint Commission, 1999).  
Furthermore, TJC suggested strategies to reduce the potential for errors related to these top five 
high-alert medications.  For three of the five high-alert medications, insulin included, TJC 
suggested the use of independent double-checks (IDC).   This publication was the earliest 
mention in the literature of a national healthcare organization-accrediting body suggesting the 
use of an IDC to reduce insulin-related medication errors.  
In addition to TJC’s publication, the Institute for Safe Medication Practices (ISMP) later 
published a more comprehensive list of high-alert medications (Institute for Safe Medication 
Practices [ISMP], 2003).  ISMP’s goal in compiling and publishing this list was to encourage 
practitioners and healthcare institutions to determine what medications for which they needed to 
develop special risk-reducing strategies.  The list, which was periodically updated, was based on 
data that the ISMP collected from its National Medication Errors Reporting Program (MERP).  
The list identified common harmful medication errors in the literature, drugs reported by 
practitioners in a survey related to errors at their facilities, and included input from medication 
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safety experts. More recently, the list has since included both subcutaneous and intravenous (IV) 
forms of insulin, with special emphasis on the frequently misused U-500, which is a highly 
concentrated solution of insulin that consists of 500 units/mL in comparison to the standard 100 
units/mL (U-100) concentration (ISMP, 2014).  Even though ISMP cited the use of IDC as one 
of the strategies to safeguard against high-alert medication errors, it also provided the caveat that 
“manual double checks are not always the optimal error reduction strategy and may not be 
practical for a few of the medications on the list” (ISMP, 2003; ISMP, 2007; ISMP 2012; ISMP 
2014).   
However, in response to the suggestions of these two nationally recognized organizations 
and TJC’s high-alert medication management accreditation standard (MM.01.01.03), some 
healthcare institutions began requiring the use of IDC prior to administration of a select few 
high-alert medications.  For example, an acute care hospital in southern California required the 
use of an IDC prior to subcutaneous administration of standard concentration (U-100) insulin to 
adults but not prior to IV administration of metoprolol and labetalol use, which have also been in 
ISMP’s high-alert medication list for as long as subcutaneous insulin has been (ISMP, 2003; 
ISMP, 2007; ISMP 2012; ISMP 2014).   
Statement of the Problem 
 In theory, IDC processes were proposed by ISMP and TJC to reduce serious medication 
errors, especially overdosing and wrong-preparation errors (Cohen et al., 1998; The Joint 
Commission, 1999).  However, there is limited evidence on whether IDC processes are effective 
in reducing these types of medication errors, especially with subcutaneous insulin.   
Furthermore, the ISMP declared rapid-acting insulins, such as insulin aspart 
(NovoLog®), as a time-critical scheduled medication (ISMP, 2011).  Time-critical scheduled 
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medications are those where early or delayed administration of greater than 30 minutes before or 
after the scheduled time may result in harm or significant sub-therapeutic or pharmacological 
effect (ISMP, 2011).  However, adult patients who are scheduled to receive subcutaneous insulin 
often do not receive their dose within 30 minutes of the scheduled dose (Modic et al., 2016).  
With the number of patients with diabetes on the rise, delayed administration of insulin could 
lead to poorer patient care outcomes. 
Background and Significance 
Diabetes mellitus has become an epidemic in the United States.  The Centers for Disease 
Control and Prevention (CDC) reports that from 1980 through 2014, the number of U.S. adults 
aged 18 years or older who were diagnosed with diabetes increased fourfold, from 5.5 million to 
21.9 million (CDC, 2015).  As of 2010, the prevalence of diabetes in the U.S. was about 1 in 10 
adults but it was projected that if the same trend were to continue (due to an aging population, 
increase in lifespan, and increase in at-risk minority groups), its prevalence would be as many as 
1 in 3 U.S. adults by the year 2050 (Boyle, Thompson, Gregg, Barker, & Williamson, 2010).  
This projected rise in the prevalence of adults with diabetes could reflect an increase in the 
number of patients who would need subcutaneous insulin during hospitalization.  Consequently, 
this could further increase the subcutaneous insulin-related workload of nurses.   
The current subcutaneous insulin-related workload of nurses usually involves an 
independent double-checking process, a process that could take an average of 5 minutes (Modic 
et al., 2016).  This can be a burden for the nurse responsible for the administration of the insulin 
as well as the nurse called upon to assist with the double-checking method.  A requirement 
placed on nurses to perform an independent double-check prior to routine subcutaneous insulin 
administration means that the primary nurse, for instance, would need to find another nurse, and 
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interrupt that nurse’s workflow.  This second nurse is required to independently look at the 
insulin sliding scale, calculate the correct dose, and compare the electronic medication 
administration record (eMAR) to the medication. 
Add into this scenario that the primary nurse may also be the one who is responsible to 
check the blood sugar (the nurse aide may not have the competency), may be in personal 
protective equipment (PPE) in an isolation room with no immediate access to a second nurse, or 
may have other patients with subcutaneous insulin needs during the same time period.  
Inconsistent patient meal delivery times may also add to the complexity of coordinating the 
timely administration of insulin.  The nurse may go through this process for up to three times for 
each insulin-needing patient in a 12-hour day shift.  Therefore, requiring nurses to perform an 
IDC prior to subcutaneous insulin administration may pose as an obstacle to the timely 
administration of a time-critical medication, such as subcutaneous rapid-acting insulin.   
Significance of the Project to Nursing 
The aim of this study was to investigate whether the current practice (of requiring an 
independent double-check prior to subcutaneous insulin administration) is still consistent with 
most current evidence.  It must be noted that there is limited literature on the effectiveness of 
IDC in reducing subcutaneous insulin-related medication errors.  A systematic review of the 
literature concluded that there is no sufficient evidence to either uphold or contest the 
effectiveness of IDC in reducing medication errors (Alsulami, Conroy, & Choonara, 2012).   
Specific to insulin, a recent study concluded that though the use of IDC prior to subcutaneous 
insulin administration was effective in reducing omission errors, it was not effective in reducing 
either wrong-preparation or wrong-dose errors (Modic et al., 2016), which are errors that The 
Joint Commission theorized an IDC would reduce (The Joint Commission, 1999).   
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Furthermore, the ISMP explicitly expressed that “the overuse of the independent double-
check for the high volume of subcutaneous insulin doses is detrimental [emphasis added] to the 
effective use of this mid-level process with other more important high-alert medications” (G. 
Banasser, personal communication, January 16, 2017).  Therefore, with this evidence-based 
practice project’s provision, practitioners and hospital policymakers can appraise additional 
evidence and decide if an IDC should continue to be required prior to subcutaneous insulin 
administration to its patient population.  This project may further contribute to the developing 
body of knowledge on this topic and could offer a reproducible model and recommendations for 
future studies.   
Project Model and Theoretical Framework 
 This project was based on a model to guide its progress and on a theoretical framework to 
explain the risks of the overuse of independent double-check processes in preventing errors 
related to high-frequency tasks, such as subcutaneous insulin administration.  
 Iowa model.  The conceptual model of this project was the Iowa Model of Evidence-
Based Practice to Promote Quality of Care (Titler et al., 2001).  The purpose of this model (see 
Appendix A) is to guide the direction for evidence-based practice (EBP) development in a 
clinical institution, such as a hospital.  This model poses that there are knowledge-focused 
triggers and problem-focused triggers that spark the need for change.  For this project, 
knowledge-focused triggers included new study findings and national organizational guidelines 
while a problem-focused trigger was derived from the identification of a clinical problem.   
 As previously mentioned, there is limited literature on the effectiveness of IDC in 
reducing subcutaneous insulin-related medication errors.  Of what is available, there is not 
adequate evidence that supports or refutes the effectiveness of the use of IDC in reducing 
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subcutaneous insulin-medication errors (Modic et al., 2016).  Furthermore, the nationally 
recognized medication safety authority, ISMP, explicitly recommends against it when used prior 
to standard concentration (U-100) subcutaneous insulin administration (G. Banasser, personal 
communication, January 16, 2017).  Therefore, this traditionally supported practice, albeit non-
evidence-based, poses a clinical problem by placing an unnecessary demand on nursing 
workload and is an obstacle to the timely administration of subcutaneous insulin.  This may 
induce financial loss to the hospital due to reduced nursing productivity secondary to an 
inefficient patient care flow process and nurse overtime wages.  This may also lead to wrong-
time (late) medication administration errors that may place patients at risk for hypoglycemia, 
which is seen in insulin stacking—the practice of administering additional doses of insulin 
before a previous dose of insulin has had its full effect (Heise & Meneghini, 2014).  These 
factors make this issue a priority for health care organizations.   
 Once a topic is considered a priority for the organization, the Iowa Model also provides 
steps to follow.  Steps include forming of a team to assemble relevant literature in order to 
critique and synthesize evidence for use in practice.  Once synthesized, the project team pilots 
the change on select units.  Outcomes to be achieved are selected, baseline data are collected, 
and EBP guidelines are designed and implemented.  Later in the pilot study, the process and 
outcomes are reviewed and evaluated.  As a result of evaluation, the practice guideline is 
modified.  Once the pilot study is completed, if stakeholders deem that the change is appropriate 
for adoption into practice, the change is implemented hospital-wide.  Outcome data are then 
monitored and analyzed to determine the impact of the change on the hospital’s staff, costs, and 
patients, ensuring the promotion of optimal patient care outcomes. 
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Human error theory.  Since this project’s interest was on whether double-checking 
causes a significant change in the incidence of medication errors, it was fitting to form a 
knowledge base of the theories behind what is thought to cause errors and how to properly 
address them.  This section examines the more encompassing human error theory.  Chapter 2 
will further explain this theory’s relationship to high-reliability theory (HRT) and normal 
accident theory (NAT). 
Human error theory poses that human errors can be approached in two ways: (a) the 
person approach and (b) the system approach (Reason, 2000).  Adherents of the person approach 
focus on the front-line people who err, holding to the belief that errors arise due to a person’s 
carelessness, inattention, and incapacity to prevent the error.  The proposed countermeasures 
appeal to people’s sense of fear through disciplinary measures such as blaming and shaming, or 
threat of litigation as means to reduce the unwanted component of human behavior.   
In contrast, the system approach holds that to err is naturally human and that “errors are 
to be expected, even in the best organizations” (Reason, 2000, p. 768).  System approach 
proponents focus on controlling the conditions (systems) under which the error occurred/could 
potentially occur.  The proposed countermeasures are based on the premise that “though we 
cannot change the human condition, we can change the conditions under which humans work” 
(Reason, 2000, p. 768).  This system approach attempts to maximize the system barriers in order 
to minimize error-provoking conditions in the front-line workplace (e.g., time pressure, fatigue, 
understaffing, inadequate resources in light of increased workload).   
Purpose/Goal of the Project 
Specific to this project, the more endorsable system approach can be applied in an 
attempt to influence the system by reducing the time pressure on nurses through altering their 
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system from an independent double-checking to a single-checking environment prior to 
performing a high-frequency task, such as subcutaneous insulin administration.  This study 
implemented a single-checking intervention to determine differences in medication errors 
between the double-checking and single-checking method and hence was an investigation into 
what factors could relieve unnecessary nurse workload and lead to a decrease in their errors. 
Study Questions 
 This study aimed to answer two questions: (1) Is there a significant difference in the 
number of subcutaneous insulin-related medication errors in adult patients who receive 
subcutaneous insulin without an independent double-check as compared to the number of 
subcutaneous insulin-related medication errors in adult patients who receive subcutaneous 
insulin after an independent double-check? and (2) Is there a relationship between select 
variables and the occurrence of a medication error?   
Definitions of Terms 
 For the purposes of this thesis project the following terms are defined: 
Medication error.  “Any error occurring in the medication use process” (Bates, Boyle, 
Vander Vliet, Schneider, & Leape, 1995).  Specifically, for this project, it involves any of the 
following four categories of errors in the administration phase: wrong-time, wrong dose, 
inappropriate omission, or wrong-preparation of subcutaneous insulin administration.  Wrong-
dose errors are further subcategorized into over-dosing and under-dosing errors. 
Wrong-time error.  Modic et al. (2016) defined a wrong-time error as “an insulin 
administration deviation greater than 30 minutes after blood glucose point-of-care testing, as the 
device downloaded results immediately to the electronic medical record [EMR]” (p. 156).   
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Because the facility that was used in this study allows for the results of blood glucose point-of-
care testing to be downloaded immediately to the EMR, this definition was maintained. 
Independent double-check (IDC).  “An independent double-check requires two people 
to separately check each component of the work process” (ISMP, 2013).  For this project, the 
IDC process necessitated the primary nurse to calculate an insulin dose, prepare the insulin pen, 
and compare the product to the actual order.  Afterwards, a second nurse independently 
(separately) checked the order with the MAR, calculated the dose, and then compared the 
primary nurse’s results with the dispensed product for verification.  Only after completing this 
double-checking process was the primary nurse allowed to administer an insulin dose.    
Single-checking.  For this project, single-checking meant that the primary nurse was 
allowed to administer an insulin dose without double-checking with a second nurse.   
Summary 
This chapter defined the problem and addressed the principal research question: “In adult 
patients who receive subcutaneous insulin, how does implementing single-checking as compared 
to independent double-checking affect medication errors?”  The background and significance of 
the problem were also addressed, given the limited evidence, and the Iowa Model was proposed 
to guide the study’s progress towards promoting evidence-based practice of insulin 
administration in the acute care hospital setting.  This chapter also provided an exploration of the 
theory behind the principal investigator’s hypothesis that reducing nurse workload (by switching 
to a single-checking culture prior to such a high-frequency task as subcutaneous insulin 
administration) may improve patient outcomes by reducing medication errors.  This chapter also 
listed key terms and presented landmark research studies on this topic as well as position 
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statements by medication safety advocate groups.  The next chapter further explores the current 
evidence on this topic.  
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Chapter 2 
 Literature Review 
 In recent decades, the independent double-checking (IDC) prior to subcutaneous insulin 
administration has been the gold standard of practice in reducing insulin-related medication 
errors among adults.  The effectiveness of this process has come into question in light of there 
being no evidence to support the notion that the traditional nursing practice of IDC reduces 
subcutaneous insulin-related medication errors.  Some well-known hospital consortiums that 
include acute care hospitals operating in multiple states do not require IDC prior to subcutaneous 
insulin administration (Kaiser Foundation Hospital/Southern California Permanente Medical 
Group [KFH/SCPMG], 2006).   
Online Poll 
 In an effort to identify which Southern California healthcare settings do not require RNs 
to perform an IDC prior to subcutaneous insulin administration in adults, the principal 
investigator (PI) conducted an informal online poll of previous nursing (RN) school classmates 
and RN coworkers through Facebook group messaging in January 2017.  Among the participants 
(N = 15), 14 worked in Southern California while 1 worked in North Carolina.  Thirteen different 
healthcare institutions were identified (10 acute-care hospitals, 1 rehab facility, 1 surgical center, 
and 1 K-12 school).  Eleven participants, each from a different institution (10 were in southern 
California and 1 was in North Carolina), said that they were required to double-check all insulin 
doses prior to administration.  One participant, the school nurse, reported lack of such a 
requirement due to the lack of another nurse in that environment.  Three participants, all from the 
same larger organization mentioned previously, reported that IDC was not required prior to 
subcutaneous insulin administration.  All but 1 of 15 participants worked with adult patients.  
INDEPENDENT DOUBLE-CHECKS AND SUBCUTANEOUS INSULIN          12 
From these findings, the PI concluded that the traditional nursing practice of conducting an IDC 
prior to subcutaneous insulin administration in adults may still be widespread among Southern 
California acute care hospitals.  
Healthcare Organizational Policy Example 
In an effort to investigate why a well-known larger organization of acute care hospitals 
does not require IDC prior to subcutaneous insulin administration in adults, the PI sought to 
locate this institution’s policy on the public Web and found a policy that covers its institutions in 
the Southern California region.  This policy states that its purpose is to standardize medication 
safety practices and to serve as the minimum standard for its Regional High-Alert Medications 
(HAM), which it claims is based on “facility data, literature, and regulatory agency standards” 
(Kaiser Foundation Hospital/Southern California Permanente Medical Group [KFH/SCPMG], 
2006).   
Interestingly, this policy identified only select forms of insulin as HAMs and requires that 
an independent double-check be performed prior to the administration of (a) all U-500 insulin 
subcutaneous doses, (b) all continuous IV insulin infusions, and (c) all routes of insulin in 
pediatric and neonatal patients.  At the time this policy was reviewed in January 2017, the policy 
did not identify subcutaneous U-100 (standard concentration) insulin as one of the insulin forms 
that need IDC prior to administration in adults.  Unfortunately, the policy did not cite the 
literature on which it based its selection of HAMs.  This prompted a review of the current 
literature on this topic. 
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The Great Debate: Double vs. Single Checking 
 In order to form a knowledge base of the current evidence that addresses the question, 
“What is the effectiveness of independent double-checking (IDC) in reducing subcutaneous 
insulin-related medication errors?” the references in the ISMP publication (2013) were 
examined.  This publication clarified ISMP’s position that IDC should be used selectively 
instead of prior to administration of all HAMs due to the time pressure theme identified in the 
literature and suggested to have played a role in failed double-checks.  The source that The Joint 
Commission (TJC) referenced in its 1999 publication, which was the earliest source found to 
have advocated for the use of IDC in reducing errors involving insulin, was also reviewed.   
A literature search of three electronic databases: Cumulative Index of Nursing and Allied 
Health Literature (CINAHL) (1983 to 2012), Nursing & Allied Health (1992 to 2016), and 
PubMed (1966 to 2016) was also conducted.  For this search the keyword ‘double check’ was 
used in combination with (Boolean operator AND) the terms ‘insulin’ or (Boolean operator OR)  
‘medication errors’ or (Boolean operator OR) ‘high alert.’  The keyword ‘double check’ was 
selected because it is the term used consistently in the PI’s hospital and other hospital policies.  
This term was also consistently used in the early ISMP and TJC newsletters that were previously 
mentioned to suggest the use of IDC as a medication error reduction strategy (ISMP, 2003; The 
Joint Commission, 1999).  When this initial search did not yield enough abstracts specific to the 
research topic, the keyword ‘double checking’ was used in combination with (Boolean operator 
AND) the term ‘insulin.’  This latter search strategy in PubMed yielded the study by Modic et al. 
(2016), which is currently the most specific and most recent study that addresses the research 
topic.  The Modic et al. (2016) study is discussed in the next section.  The following are the 
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studies deemed noteworthy for their early works, specificity regarding the research topic, and 
insight into the attitudes of clinicians from a double-checking to a single-checking environment.   
 Early landmark study.  When The Joint Commission (TJC) advocated for the use of 
IDC in an effort to reduce errors involving insulin (1999), it cited a study by ISMP’s Cohen et al. 
(1998), which surveyed the nation’s hospitals of which systems-oriented factors allowed for their 
highest level of medication safety.  The 156 medical-surgical hospitals from 37 states that 
participated provided a total of 951 serious medication error incidents.  Serious medication errors 
were categorized as follows: (a) level 4 errors were errors that resulted in needed intervention to 
prevent permanent damage to the patient; (b) level 5 errors were errors that resulted in permanent 
patient harm; and (c) level 6 errors were errors that resulted in patient death (Cohen et al., 1998).  
Cohen et al. (1998) found that over one-third of all medication errors the hospitals reported 
involved the following six categories: allergies, heparin, opiates, patient-controlled analgesia 
(PCA) devices, potassium concentrates, and insulin.  
Insulin errors accounted for 11% (n = 105) of all error reports, one of which involved a 
level 6 error.  All remaining 104 incidents involved level 4 errors, among which certain themes 
were identified: (a) the inappropriate use of “U” as abbreviation for units; (b) mix up with 
heparin 100-unit vials; (c) wrong rate or amount resulting in 10 to 100-fold overdoses; (d) wrong 
insulin type used (regular instead of NPH); (e) wrong patient; and (f) duplicative dosing.  
Though this landmark study identified these themes related to insulin medication errors, it did 
not specify whether subcutaneous routes of insulin were involved in errors, making the findings 
less generalizable to patient populations receiving subcutaneous insulin.   
Another limitation to the Cohen et al. study (1998) is that the survey period was from 
1994 to 1995 when barcode scanning technology was provided by only 0.6% of the surveyed 
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hospitals as a measure in place to prevent administration errors, such as heparin mix-ups, wrong 
insulin type, and wrong patient errors—error categories reported in this study.  Furthermore, in a 
more technologically advanced environment where all subcutaneous insulin orders are 
electronically entered through a computerized provider order entry (CPOE) system (instead of 
free-texted), it is theoretically impossible for prescribers to inappropriately use “U” as 
abbreviation for units and for nurses to misinterpret the “U” as “0.”  These limitations further 
make the study’s findings of the incidence of insulin-related medication errors less generalizable 
to modern hospital environments where barcode scanning and CPOE technology are in place to 
prevent 4 of the 6 administration errors cited in the findings.  Therefore, in view of the present-
day use of scanning procedures with medication administration, the need for further research 
providing current evidence on this topic is essential to optimal nursing practice.  
Most relevant and recent quantitative study.  In this most recent study, Modic et al. 
(2016) conducted a quasi-experimental study to determine the effectiveness of double-checking 
in reducing medication errors at a single-checking hospital.  The authors found that out of 5,238 
subcutaneous insulin administration opportunities, 1,763 were involved in errors (wrong-time, 
wrong-dose, wrong-preparation, omission errors).  Of these, only 1.13% (n = 20) were involved 
in wrong-dose errors.  In contrast, 92.5% (n = 1,630) involved wrong-time errors. 
The authors defined a wrong-time error as “an insulin administration deviation greater 
than 30 minutes after blood glucose point-of-care testing, as the device downloaded results 
immediately to the electronic medical record” (p. 156).  This definition is consistent with the 
ISMP’s declaration that rapid-acting insulins, such as insulin aspart (NovoLog®), are a time-
critical scheduled medication (ISMP, 2011).  Time-critical scheduled medications are those 
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where early or delayed administration of greater than 30 minutes before or after the scheduled 
time may result in harm or significant sub-therapeutic or pharmacological effect (ISMP, 2011). 
Though the authors speculated that the reason for the dominance of wrong-time errors 
could be due to several non-nurse-contingent factors, such as unavailability of the medication 
and ambiguous prescription orders that require communication with the prescriber, they did not 
suspect that the additional IDC intervention contributed to the time delay.  Their reasoning was 
due to the excessive amount of wrong-time errors in both the IDC-performing intervention group 
(27.6%, n = 551), and the single-checking control group (33.3%, n = 1,079).  However, after 
controlling for the single nurse giving insulin, the double-checking intervention was found to 
have been effective in decreasing omission errors only, but not any other errors.   
Interestingly, the authors stated that the average time that it took to complete an IDC was 
five minutes, which could theoretically be a contributing factor to patients not receiving their 
dose within the prescribed 30 minutes.  This poses the question of whether there is a significant 
relationship between the presence or absence of IDC and wrong-time errors.   
The authors concluded that although double-checking insulin was originally theorized 
and proposed as a strategy to reduce wrong-dose and wrong-preparation errors (The Joint 
Commission, 1999), the intervention failed to reduce these types of errors at their acute care 
hospital.  Modic et al. (2016) called for future studies to investigate how to reduce wrong-time 
errors, which they thought were also the most prevalent type of subcutaneous insulin-related 
medication error in other hospital settings.   
Systematic review.  To determine the evidence on the effectiveness of IDC in decreasing 
medication error rates, Alsulami, Conroy, and Choonara (2012) conducted a systematic review 
of 6 electronic databases—Embase, Medline, British Nursing Index and Archive, CINAHL, 
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National electronic Library for Medicines (NeLM) and PsycINFO—for articles describing IDC 
use for dose calculation, dispensing, and administration in adults and children up to October, 
2010.  Although the search yielded 752 abstracts, all but 106 were unrelated to double-checking 
in the medication process.  After the full text of each of the 106 articles was reviewed, 92 were 
further excluded due to being unrelated to double-checking medications.  After manual review of 
the 14 articles’ references, two more studies were added, totaling 16 articles.  The 16 articles 
included (a) 3 quantitative studies, (b) 2 mixed-methods studies, (c) 9 qualitative studies, and (d) 
2 previously conducted systematic reviews.  Two of these are relevant to this project. 
Quantitative study.  One of the three quantitative studies was a randomized controlled 
clinical trial conducted over a 46-week study period.  This study, which detected 319 errors 
among 129,234 medications in a geriatric unit, showed a statistically significant reduction in the 
medication error rate from 2.98 to 2.12 per 1000 medications when two nurses administered the 
medications compared to a single nurse (Kruse, Johnson, O'Connell, & Clarke, 1992). Through a 
time and motion study, Kruse et al. (1992) indicated that this reduction in errors came at a cost of 
an additional 17.1 hours of nursing time required per 1000 medications administered.  The 
authors concluded that the high cost on nursing workload would make the intervention time-
consuming, impractical, and thus, un-endorsable.   
Mixed-method study.  Jarman, Jacobs, and Zielinski (2002) conducted a 
descriptive/observational study evaluating the effect of a policy change that was introduced in an 
Australian hospital whereby single-checking replaced the historically performed double-
checking of a list of medications, including “insulin according to sliding scale,” over a period of 
seven months.  The quantitative part of the study had two data collection sources.  One involved 
tracking incident reports, which showed there were only five related error incident reports filed 
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during the double-checking period compared to four error incident reports filed during the 
single-checking period.  Although this source had its limitation due to a small sample and its 
method of tracking errors through nurse-initiated incident reports, the other quantitative data 
source contributed to the evidence related to the impact of single-checking on nurses.  
After the seven-month study, a 15-item questionnaire asked nurses (N = 129) about the 
following: (a) level of satisfaction with single-checking, (b) perceived level of responsibility and 
confidence with single-checking, and (c) the extent to which the change to single-checking had 
decreased the amount of time taken for the administration of medications.  The nurses reported 
(a) high levels of satisfaction with the change, (b) high levels of responsibility and confidence as 
a result of the change, and (c) that the change had a high impact on the amount of time taken to 
give medications, with the perceived average amount of time saved being 20 minutes.   
The questionnaire’s open-ended questions yielded qualitative data that revealed recurring 
themes. With regards to the high levels of responsibility, the nurses reported heightened self-
accountability through statements of “I read the order more carefully,” “I am extremely thorough 
and take more time, knowing I am not holding up someone else,” and “I double-check 
everything with myself before administering the drug.”   
With regards to the nurses’ perception of the effectiveness of single-checking in saving 
time, nurses reported that time-savings came from not having to find a second nurse (particularly 
important to night shift nurses) and interrupt colleagues or be interrupted by them.  The nurses 
reported that the time saved from not having to double-check medications enabled them to 
administer medications in a timely manner and provided them additional time to be with their 
patients, increasing their level of satisfaction and autonomy.   
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Continuation of the Frameworks 
As previously mentioned, this project was based on the Iowa Model to guide its progress 
and on the human error theory to explain the risks of the overuse of independent double-check 
processes in preventing errors related to high-frequency tasks, such as subcutaneous insulin 
administration.  The Iowa Model of Evidence-Based Practice to Promote Quality of Care (Titler 
et al., 2001; see Appendix A) is used to guide the direction for evidence-based practice (EBP) 
development in a clinical setting, such as a hospital.  Since there is not sufficient evidence to 
support or refute the effectiveness of the use of IDC in reducing subcutaneous insulin-medication 
errors, the Iowa Model suggests moving forward either (a) by basing practice on other types of 
evidence (such as case reports, expert opinion, scientific principles, theory) or (b) by conducting 
research.    
Expert opinion as evidence.  The expert opinion of the Institute for Safe Medication 
Practices (ISMP) states the following: 
ISMP has never explicitly encouraged the regular use of IDC’s for subcutaneous insulin 
(other than U-500).  For intravenous (IV) insulin, ISMP does support an independent 
double-check (IDC).  The ISMP High-Alert Medications list notes that “manual 
independent double-checks are not always the optimal error-reduction strategy and may 
not be practical for all of the medications on the list.”  The overuse of the independent 
double-check for the high volume of subcutaneous insulin doses is detrimental [emphasis 
added] to the effective use of this mid-level process with other more important high-alert 
medications. (G. Banasser, personal communication, January 16, 2017) 
The ISMP is nationally recognized by medication safety teams and by The Joint Commission as 
an authority and advocate for safe medication practices. 
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Error theory as evidence.  Additionally, the Iowa Model allows theory to be a type of 
evidence (Titler et al., 2001).  There are several theories behind what is thought to cause errors 
and how to properly address them.  While Chapter 1 mainly explored the more encompassing 
human error theory by Reason (2000), Chapter 2 explores this theory’s relationship to high-
reliability theory (HRT) and normal accident theory (NAT).   
To review, the system approach to human error theorizes that to err is naturally human 
and that attempts must be focused on maximizing system barriers in order to minimize error-
provoking conditions in the workplace.  This system approach is in contrast to the person 
approach that is more focused on error-reduction among the front-line defense that consists of 
fallible humans.  Since double-checking requires that one imperfect person check the work of 
another flawed human, it is not always the optimal system approach to reducing medication error 
(ISMP, 2003; ISMP, 2007; ISMP 2012; ISMP 2014).  Due to the tendency of people to see what 
they expect to see, the effectiveness of double-checking is diminished (ISMP, 2003; Reason, 
1990).   
The system approach is consistent with the assumption that “though we cannot change 
the human condition, we can change the conditions under which humans work” (Reason, 2000, 
p. 768).  In an effort to improve the system (reduce medication errors) under which bedside 
nurses work, the time pressure that comes with an independent double-check must be relieved 
since it was previously theorized and found to have had some contribution to the nurse workload 
associated with a high-frequency task such as subcutaneous insulin administration (Jarman et al., 
2002).  Furthermore, the high-reliability theory (HRT) and normal accident theory (NAT) 
provide unique perspectives on the limitations of independent double-checks in reducing system 
errors.  
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High-reliability theory.  U.S. Navy nuclear aircraft carriers, nuclear power plants, and air 
traffic control centers are three types of high-reliability organizations (HRO) that have been 
identified to be “systems operating in hazardous conditions that have fewer than their fair share 
of adverse events” (Reason, 2000).  High-reliability theory’s main concern is to assure the 
reliability of procedures in high-hazard settings (Tamuz & Harrison, 2006), making it applicable 
to hospital procedures.  One of the ways that reliability is enhanced is through redundancy, 
provided that it is selective.  The ISMP said the following warning against the non-selective use 
of IDC: 
With workload issues looming heavily over practitioners, independent double checks 
should only be used for very selective high-risk tasks or high-alert medications (not all) 
that most warrant their use.  Selected tasks and medications should not be based simply 
on those which have historically always been double checked, but on a careful 
assessment of scenarios with the greatest risk.  As such, ISMP does not recommend use 
of an independent check for all high-alert medications or all high-risk tasks… Fewer 
double checks strategically placed at the most vulnerable points of the medication use 
process will be much more effective than an overabundance of double checks. (ISMP, 
2013) 
High-reliability theory proposes a selective use of redundancy processes, like IDC, because an 
overreliance on double-checking is thought to actually reduce one’s mindfulness of the safety 
risks involved, possibly inducing front-line workers (such as nurses) to consider the requirement 
common and superficially routine. 
 Normal accident theory.  Normal accident theory (NAT) attempts to “raise awareness of 
unavoidable risk of major system failures in industries using tightly coupled, interactively 
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complex technologies” such as nuclear power plants, where there is low tolerance for system 
failures combined with a considerable risk for accidents (Tamuz & Harrison, 2006).  This 
framework also helps demonstrate the limits of redundancy by highlighting that redundancies 
can contribute to accidents when they lack independence, increase complexity, and diffuse 
personal responsibility (Sagan, 2004).  This is consistent with the findings of the following 
qualitative study. 
 Armitage (2008) investigated the themes involved in medication errors that occurred 
while double-checking was in place at a large teaching hospital in the U.K by interviewing a 
sample (N = 40) of 15 doctors, 15 nurses, 7 pharmacists and 3 pharmacy technicians who had 
experience with drug errors.  As a result of the study, the following 4 categories of criticisms 
regarding IDC were identified: (a) deference to authority (n = 9), in which junior members 
reported deferring to the calculation of more senior colleagues without independently checking 
their calculation; (b) reduction of responsibility (n = 10), in which the clinician reported being 
complacent due to a false sense of diffused responsibility, thinking that another clinician will 
detect his/her mistake; (c) automatic processing (n = 9), in which the clinician reported not 
performing the calculation independently due to being in mindless “autopilot” mode and in 
contrast to proper IDC where second checker is separated by time and distance; and (d) lack of 
time (n = 10), in which the clinician reported being time-poor, lowering his/her quality of 
adherence to proper IDC.   
A limitation of this study is that not all participants were critical of the process, which 
accounted for only 38 tabulated responses, where some participants provided more than one 
criticism.  It is interesting to note that the participants without criticisms against IDC primarily 
held more senior, management level positions.  
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Additionally, double-checking procedures may delay the identification and correction of 
errors (Reason, 1997).  For example, if during a double-check, a mistake is detected and 
corrected by hospital pharmacy staff before it reaches the patient, the mistake may not be 
classified and reported as an error.  Such misinterpretation may delay or altogether miss the 
opportunity for a root cause analysis to occur and prevent similar errors from happening again 
(Tamuz & Thomas, & Franchois, 2004).   
Summary 
This chapter discussed a survey of nurses’ current practice surrounding double-checking 
subcutaneous insulin and further examined error theories and literature, supporting the need to 
investigate this topic.  Hospital policymakers need to be aware of the limitations documented in 
the literature related to independent double-checking.  In an effort to progress the institution 
toward a safe, high-reliability organization (HRO), organizations must recognize that though 
“human variability is a force to harness in averting errors” leaders must also “work hard to focus 
that variability and…constantly [be] preoccupied with the possibility of failure” (Reason, 2000).  
HROs need to consider accomplishing this through a systems approach where those at the blunt-
end of errors (i.e., those in managerial or policy-making positions) modify the conditions under 
which those at the sharp-end work (i.e., frontline workers).  A hospital organization that seeks to 
be an HRO must recognize that to err is naturally human and that with a systems approach, 
minimizing the factors that could provoke errors would be a better approach than relying on 
techniques that are contingent on its fallible front-line workers.  
The next chapter presents the design and methodology of the project that was conducted 
to investigate if there would be a difference in medication errors surrounding nurses’ 
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subcutaneous insulin administration when their system is altered from an independent double-
checking environment to a single-checking culture.   
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Chapter 3 
 Methodology 
 This quantitative quasi-experimental project was composed of a two-phase pilot study 
that replicated parts of the design and methods used in the study by Modic et al. (2016).  This 
study investigated if there would be a difference in medication errors related to subcutaneous 
insulin while single-checking was in place compared to when independent double-checking 
(IDC) was in place.  Additionally, this pilot study aimed to investigate if there was a relationship 
between select variables and the occurrence of a medication error involving subcutaneous 
insulin.  This chapter details the design and methods used to develop and implement the two-
phase pilot study.  
Target Population and Setting 
 The project was approved by the hospital’s Institutional Review Boards (IRB) through 
expedited review (see Appendix B) as a two-phase pilot study at a 27-private-bed progressive 
care unit in a southern California acute care hospital.  This sub-intensive care unit (Sub-ICU) 
serves an adult population with lower acuity than that of a standard intensive care unit (ICU).  
However, the patients require a higher level of care than those generally found on a telemetry or 
medical-surgical unit.  Its registered nurses (RNs) are trained to care for those who need 
continuous telemetry monitoring, mechanical ventilation (tracheostomies and bilevel positive 
airway pressure [BiPAP]) and select un-titratable vasopressors at preset limited doses.  
Maximum nurse to patient ratio is 1:3.  Sub-ICU RNs routinely administer rapid-acting and long-
acting subcutaneous insulin doses with the use of patient-exclusive multi-dose insulin pens 
(NovoLog® FlexPen® and Lantus® SoloSTAR®, respectively) with the standard concentration 
of 100 units/mL (U-100).  Before this project, RNs were required to perform double-checking 
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prior to administration of a U-100 subcutaneous insulin dose; however, they were not required to 
do so prior to withholding a dose.  Computer workstations on wheels (WOWs) are used to access 
patients’ electronic health records (EHR), including the electronic medication administration 
record (eMAR).  The EHR system at the time of the pilot study was called Allscripts Sunrise 
Clinical Manager ™ (SCM). 
Inclusion and exclusion criteria.  Adult patients (at least 18 years of age) who were 
admitted to the Sub-ICU from November 10, 2017 at 0700 through January 1, 2018 at 0659 were 
included into the convenience sample, provided that they had subcutaneous insulin ordered in U-
100 concentration (100 units/mL); the PI set audit filters in the EHR to track these patients into a 
patient list.  For assessment of wrong-time errors, only those on blood glucose monitoring 
(Accu-chek®) every 4 hours (scheduled at 0800, 1200, 1600, 2000, 0000, and 0400) and those 
for whom long-acting insulin was ordered outside of mealtimes (i.e., scheduled at bedtime) were 
included.  Mealtime-related insulin doses were excluded from wrong-time error assessment due 
to the complexity in controlling for their timeliness given varying length of times that patients 
take to complete meals.  To review, the definition of a wrong-time error in this study is 
consistent with that of Modic et al. (2016) as “an insulin administration deviation greater than 30 
minutes after blood glucose point-of-care testing, as the device downloaded results immediately 
to the electronic medical record” (p. 156).  The facility used in this study allowed for the results 
of blood glucose point-of-care testing to be downloaded immediately to the EHR along with a 
time stamp. 
 Subcutaneous insulin documentation by full-time, part-time, and per diem RNs that were 
regular Sub-ICU staff who had gone through or were going through orientation in Sub-ICU were 
included in data collection during both phases, provided that the RN (1) had successfully 
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returned demonstration with the principal investigator (PI) on how to calculate the subcutaneous 
insulin dose and (2) had acknowledged electronic receipt and understanding of the pilot manual.  
By the start of this project, 47 Sub-ICU RNs were eligible to participate.  In the middle of the 
project, four Sub-ICU RNs returned from their leaves of absence and two more RNs were newly 
hired to Sub-ICU.  Therefore, by the end of this project, a total of 53 Sub-ICU RNs were eligible 
to participate.  During the single-checking phase, subcutaneous insulin documentation by visiting 
(“floating”) RNs and nursing students were excluded from the sample selection.  
Project Procedures 
 Phase 0: Pre-pilot briefing sessions.  Before the actual pilot study was implemented, the 
PI met numerous times with Sub-ICU RNs individually and in small group in-service sessions to 
brief them face-to-face about the aim of the pilot study and its scope in the Sub-ICU.  Each 
session lasted 10-15 minutes, with the number of participant RNs fluctuating each session 
depending on RN availability on a given shift.  The main objective of these sessions was for the 
Sub-ICU RN to demonstrate the correct method in calculating the appropriate insulin dose for an 
example situation, using the hospital’s sliding scale and algorithm ratios, especially because 
there had been certain situations where the PI noticed inconsistent calculation methods among 
RNs which sometimes yielded different doses (e.g., when patient parameters fall outside the 
sliding scales).  The PI printed copies of the hospital’s sliding scale and algorithm ratios and 
distributed these to the Sub-ICU RNs in each session.  The PI then asked the Sub-ICU RNs how 
much subcutaneous insulin they would give a patient in three different scenarios (see Appendix 
C).  At the end of the session, the PI showed the Sub-ICU RNs a sample of the “Errors 
Prevented” form (see Appendix D, Figure D1) and answered participant questions.  A four-page 
pilot manual was also emailed to these RNs as a reference for the workflow changes during the 
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two phases of the pilot study (see Appendix D).  At the start of the pilot study, a hardcopy of the 
manual was also printed in heavy cardstock and placed in the unit’s medication preparation room 
for easy access. 
 Phase 1: Double-checking phase.  The first phase, which was double-checking, 
functioned as a control since double-checking was the hospital standard prior to this project.  
This phase lasted 3 weeks, from November 10, 2017 at 0700 until December 1, 2017 at 0659.  
Per hospital policy and approved pilot protocol, the double-checking process and subcutaneous 
insulin administration (if indicated) consisted of the following steps:  
1.  After the primary RN checked the patient’s blood sugar and/or grams of carbohydrates 
eaten, he/she (a) calculated the appropriate insulin dose per the ordered algorithm ratio in 
the eMAR; (b) prepared the insulin pen if a dose was indicated; and (c) verified that the 
insulin pen had the appropriate patient label and expiration date. 
2.  The primary RN sought a second RN to participate in an IDC, regardless if insulin 
administration was deemed unnecessary.   
3.  The second RN verified the blood glucose result that was charted in the EHR or 
shown in the blood glucose meter (Accu-chek®), obtained for that insulin administration 
period.  If insulin was also ordered for carbohydrate coverage, the second RN verbally 
verified with the primary RN the grams of carbohydrates the patient ate. 
4.  If the patient met criterion/a for administration of an insulin dose, the second RN 
reviewed the eMAR for which of the four insulin dosing algorithms was ordered and 
calculated the dose indicated.  The second RN inspected the dose that the primary RN 
dialed on the insulin pen and confirmed it was the correct insulin pen (e.g., correct patient 
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label, current expiration date).  The primary RN opened the insulin eMAR task and 
entered the second RN’s name in the mandatory co-signature field. 
5.  If the patient did not meet criterion/a for administration of an insulin dose, the second 
RN verified that the dose should be held.  On the eMAR task, the primary RN entered 
“0” units to be given and entered the second RN’s name in the mandatory co-signature 
field.  The primary RN did not administer a dose. 
6.  Afterwards, the pair filled out one preprinted “Errors Prevented” form (see Appendix 
D, Figure D1), whether the pair decided to administer or omit a dose.  They inserted the 
form into a designated, locked drop box (see Appendix D, Figure D2) located in the Sub-
ICU medication room.  The preprinted forms were stocked in close proximity to the drop 
box, which was in bright red color for easy visibility. 
7.  If a dose was indicated and confirmed by the second RN, the primary RN brought a 
WOW into the patient’s room and opened the eMAR.  The hospital’s barcode scanning 
process for medication administration was followed: The primary RN scanned the 
patient’s armband and the insulin pen barcode before administering the dose 
subcutaneously.   
 Phase 2: Single-checking phase.  During the second phase, which was the intervention 
phase, the Sub-ICU RN was temporarily allowed to administer subcutaneous insulin (U-100) to 
Sub-ICU patients without performing an IDC with a second RN.   This phase lasted 4 weeks, 
from December 1, 2017 at 0700 until January 1, 2018 at 0659.  Per IRB-approved pilot protocol, 
the single-checking process consisted of the following steps:  
1.  The primary RN checked the patient’s blood sugar and/or grams of carbohydrates 
eaten.  
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2.  If the patient met criterion/a for administration of an insulin dose, the primary RN (a) 
calculated the appropriate insulin dose per the ordered algorithm ratio in the eMAR, (b) 
prepared the insulin pen, and (c) verified that the insulin pen had the appropriate patient 
label and expiration date.  The primary RN entered the name of the principal investigator 
(PI) in the eMAR insulin task’s mandatory co-signature field as a work-around since the 
hospital’s information technology (IT) department could not selectively turn off this 
mandatory field for one department only.  In other words, the PI became the primary 
RN’s imaginary double-checker for the purpose of completing the eMAR insulin task 
documentation.  This step “pushed” notifications to the PI’s Signature Manager Inbox. 
3.  If the patient did not meet criterion/a for administration of an insulin dose, on the 
eMAR task, the primary RN entered “0” units to be given and entered the PI’s name in 
the mandatory co-signature field for the same reason as stated in step 2.  The primary RN 
did not administer a dose. 
4.  If a dose was indicated, the primary RN brought a WOW into the patient’s room and 
opened the eMAR.  The hospital’s barcode scanning process for medication 
administration was followed: The primary RN scanned the patient’s armband and the 
insulin pen barcode before administering the dose subcutaneously.   
5.  Because the PI used eMAR task audits as the main error assessment tool during the 
single-checking phase, the RN did not use the “Errors Prevented” form (see Appendix D, 
Figure D1) that was used during the double-checking phase.  However, because there was 
no other method to audit wrong-preparation errors (e.g. wrong insulin pen used for 
patient) from performing eMAR task audits, the Sub-ICU RN was instructed to self-
report such an event.  If the RN made a wrong-preparation error that he/she contributed to 
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the lack of a double-checking requirement, he/she was instructed to self-report through 
filling out an anonymous “Self-Report of Wrong-Preparation Error” form (see Appendix 
D, Figure D3) and filing an online internal risk management report called “MIDAS.”  
Preprinted self-report forms were stocked in close proximity to the red drop box in the 
medication room.  The RN was instructed to insert this form into the locked red drop box.  
Instrumentation 
 Phase 1: Double-checking phase.  Modic et al. (2016) provided preprinted cards for 
nurses to use as a means of reporting the type of insulin errors prevented by an IDC.  Similarly, 
this project’s PI designed this project’s “Errors Prevented” form, though with less words and 
with bolded text of key words for easy visualization (see Appendix D, Figure D1).  These forms 
were preprinted and made accessible to Sub-ICU RNs in the Sub-ICU medication room.  Each 
pair of Sub-ICU nurses was instructed to fill out one card anonymously for every IDC they 
performed prior to administration or omission of a subcutaneous insulin dose.  These forms were 
stocked next to the red drop box (see Appendix D, Figure D2).  Day shift RNs (shift hours from 
0700-1930) were instructed to use the forms printed in pink cardstock while night shift RNs 
(1900-0730) were instructed to use forms printed in blue cardstock.  The color of form used 
during the 30-minute shift change overlap period depended on which shift the primary RN 
worked. 
 Phase 2: Single-checking phase.  As previously mentioned, if the RN made a wrong-
preparation error that he/she contributed to the lack of a double-checking requirement, he/she 
was instructed to self-report through filling out an anonymous “Self-Report of Wrong 
Preparation Error” form (see Appendix D, Figure D3) and filing an online internal risk 
management report (“MIDAS”).  
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Data Collection and Analysis  
 Collection.  Demographic data collected (through EHR chart review) from patients 
whose medication administration were recorded in the study were age, gender, diabetes type, and 
isolation precaution type.  Although no direct nurse demographics were collected, the shift type 
(day or night) of the administering RN was collected.  Outcome measures and their data 
source(s) are listed in Table 1.  The hospital’s internal risk management software (“MIDAS”) 
was also used as an additional data source for all outcome types although it must be noted that 
these types of reports are clinician-initiated and are seldom filed, possibly due to the long filing 
process involved.  For example, between July 2016 and December 2016, only 5 insulin-related 
errors were filed.  This is why eMAR task audits and the preprinted forms were used as the main 
data sources to track outcome measures. 
Table 1 




Data source during DOUBLE-
checking 
Data source during  
SINGLE-checking 
Wrong-time (only for doses 
scheduled every 4 hours and 
non-mealtime Lantus doses) 
eMAR audits  eMAR audits 
Wrong-dose (over-dosing and 
under-dosing) 
eMAR audits  eMAR audits 
 
Inappropriate omission eMAR audits  eMAR audits 
 
Wrong-preparation “Errors Prevented” form 
 
“Self-Report of Wrong 
Preparation Error” form 
No insulin errors prevented eMAR audits  
 
eMAR audits 
Note.  The hospital’s internal risk management software (“MIDAS”) was used as an additional 
data source for all outcome types.  eMAR = electronic medication administration record.   
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 Analysis.   The Statistical Package for the Social Sciences (SPSS, version 24) software 
was used to analyze the data.  Descriptive statistics were used to analyze means, standard 
deviations, frequencies, and percentages of demographic variables and outcome measures.  
Inferential statistics were conducted using: (a) an independent samples t-test to determine 
differences between the control group (double-checking phase) and the experimental group 
(single-checking phase); and (b) chi-square test of independence to determine the difference 
between frequencies of the nominal variables between the two groups.  Significant differences 
between the control and experimental groups were determined by a p value set at £ .05.  Single 
and multiple categorical logistic regression tests were used to control for demographic variables.  
A Pearson r correlation test was performed to determine if there was a relationship between 
select variables and medication error likelihood.  Furthermore, an analysis of variance (ANOVA) 
and subsequent post-hoc tests were conducted to determine which of the isolation precaution 
types had a significant effect on the time lapse (in minutes) between the blood glucose check and 
the administration of the insulin dose. 
Human Subjects Protection 
 In order to comply with the hospital’s and Vanguard University’s regulations regarding 
human subjects protection, the principal investigator (PI) obtained training (see Appendix E) 
from the Collaborative Institutional Training Initiative (CITI) online program and training 
modules from the National Institutes of Health (NIH).   Nurses’ and patients’ confidentiality 
were observed according to the Health Insurance Portability and Accountability Act (HIPAA) 
regulations as follows:  
 General principles.  Only the PI had access to identifiable data.  The thesis advisor and 
the university’s statistician were given access to non-identifiable data in order to assist with data 
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analysis; the hospital’s Clinical Research Office (CRO) and Nurse Research Council (NRC) were 
also given access to the non-identifiable data in order to comply with the hospital’s pilot study 
data report-back guidelines. 
Data handling procedures.  Patients’ confidentiality was observed according to the 
HIPAA regulations in that the collective (rather than individual) demographic data of the sample 
(with no patient identifiers) were stored in the PI’s password-protected Macbook laptop.  These 
files, which had no patient identifiers, only contained age, gender, diabetes type, and isolation 
type demographic data.  On the other hand, data with identifying patient information were stored 
in the form of a password-protected electronic file that was saved in the PI’s hospital IT-generated 
and secured computer directory.  Hospital IT confirmed that this directory and the files contained 
within it were, are, and will only be accessible to the PI through her unique network credential 
username and password, which were not shared with anyone.     
During eMAR task audits, it was inevitable for the PI to see the identifying information of 
the patients who were given subcutaneous insulin and of the nurses who were involved in 
subcutaneous insulin medication administration.  During these eMAR audits, patients’ visit 
account numbers (VANs) were collected while identifiable nurse data were not collected.  
During these eMAR audits, the investigator maintained a Microsoft Excel worksheet, identified 
here as “Worksheet 1” (see Appendix D, Figure D4).  The password required to open Worksheet 
1 was only known to the PI and consisted of at least 12 characters with lowercase letters, 
uppercase letters, numbers, and a special character.  Summarized tallies of the data from 
Worksheet 1 (e.g., the number of wrong dose incidents on a given date) without patient 
identifiers were stored in the form of other Microsoft Excel worksheets, saved in the 
investigator’s password-protected Macbook computer.  In summary, electronic files with patient 
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identifiers did not leave the hospital’s secured computer network system.  Only files with non-
identifiable data were stored in the investigator’s password-protected Macbook laptop.   
 Data destruction procedures.   
 Destruction of identifiable data.  Files with identifiable data (i.e., Worksheet 1) will be 
destroyed no earlier than December 2019.  This will allow time for any record review at the 
hospital, should the data’s validity be questioned.  The electronic file will then be disposed of by 
electronically deleting the file from the hospital-secured computer and subsequently emptying its 
“Recycle Bin.”   
Destruction of non-identifiable data.  Since the PI intends to publish findings or 
disseminate non-identifiable data results outside of the University, it may be necessary to keep 
the non-identifiable data for an undetermined length of time.   
Summary 
This chapter described the design and methodology of the thesis project that was 
conducted to investigate: (1) if there would be a difference in medication errors related to 
subcutaneous insulin while single-checking was in place compared to when double-checking was 
in place and (2) if there would be a relationship between select variables and the occurrence of a 
medication error involving subcutaneous insulin.  Inclusion and exclusion criteria used in 
accessing the convenience sample were identified as well as the step-by-step procedures 
implemented during the two-phase pilot study.  Tools used to compare the data before and during 
the intervention, and statistical analyses were also discussed.  Furthermore, this chapter 
explained how data files were and will be stored and destroyed in a confidential manner, in 
keeping with human subjects protection.  The next chapter will present the study’s results. 
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Chapter 4 
 Results 
 This quantitative quasi-experimental pilot study aimed to answer two questions: (1) Is 
there a significant difference in medication errors related to subcutaneous insulin while single-
checking is in place compared to when independent double-checking (IDC) is in place; and (2) Is 
there a relationship between select variables and the occurrence of a medication error involving 
subcutaneous insulin?  This chapter details the analysis performed on the data collected and the 
results that answer the questions of this two-phase pilot study.   
Data Levels of Measurement 
 The collected data were numerically coded in Microsoft Excel and imported into the 
Statistical Package for the Social Sciences (SPSS, version 24) software for data analysis.  Table 
2 lists each variable’s level of measurement.  
Table 2 
Data Variables and Their Selected Levels of Measurement 
Variable 
 
Nominal Ratio (“Scale” in 
SPSS) 
checking type X  
age (in years)  X 
gender X  
DM type X  
isolation type X  
shift type X  
time lapse (in minutes)  X 
wrong-time  X  
over-dosed X  
under-dosed X  
inappropriate omission X  
wrong BG charted X  
wrong preparation X  
Note.  SPSS = Statistical Package for the Social Sciences; DM = diabetes mellitus; BG = blood 
glucose. 
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Data Analysis 
 As mentioned in Chapter 3, descriptive statistics using means, standard deviations, 
frequencies, and percentages were used to analyze demographic variables and outcome 
measures.  Inferential statistics were conducted using: (a) independent samples t-test to compare 
the means between the control group (double-checking phase) and the intervention group (single-
checking phase) and (b) chi-square test of independence to determine the difference between 
frequencies of the nominal variables between the two groups.  Significant differences between 
the control and intervention groups were determined by a p value set at £ .05, with all tests 2-
sided.  A Pearson r correlation test was also performed to determine if there is a relationship 
between sample variables and likelihood of medication error occurrence.  Furthermore, an 
analysis of variance (ANOVA) and a post-hoc test were conducted to determine which of the 
isolation precaution types had a significant effect on the time lapse (in minutes) between the 
blood glucose check and the administration of the insulin dose.  Single and multiple categorical 
logistic regression tests were also performed to control for demographic variables.   
The Findings and Interpretation 
 Demographics of double-checking and single-checking groups.  Over a seven-week 
period, there were a total of 1,528 opportunities (collected through eMAR chart audits) for 
subcutaneous insulin administration and omission among the 92 patients that were included in 
the sample.  Patient mean age was 72.15 (±15.1) years and 56.5% (n = 52) were male.  Table 3 
provides a comparison of the 92 patients’ characteristics between the double-checking (n = 37) 
and the single-checking (n = 55) groups although it does not include the isolation type 
demographic variable because the PI noticed that depending on the date and time, a patient could 
have different isolation status (i.e., placed in enteric isolation after stool tested positive for C. 
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difficile).  Table 3 shows that there was no significant difference in the age, gender, or diabetes 
type between the two groups (p > .05).    
Table 3 
Characteristics of the Sample Patients  
Variable Double-
checking 
group (n = 37) 
Single-
checking 
group (n = 55) 
t c2  p 
Value 
 
Age, in years M = 72.30 
SD = 14.9 
M = 72.05 
SD = 15.365 
.075 N/A .94 
 
Gender (n) 
  Male 
 













DM type (n) 
  Type 1 
  Type 2 
  None 
  None, but on steroids 
  Pre-diabetes 
  Gestational 
  Unknown 
  Unknown, but on steroids 
  Unspecified 
  Unspecified, but on 
steroids 
 
5.4%  (2) 
35.1%  (13) 
2.7%  (1) 
5.4%  (2) 
2.7%  (1) 
0 
5.4%  (2) 
5.4%  (2) 
32.4%  (12) 
5.4%  (2) 
 
0 
41.8%  (23) 
1.8%  (1) 
1.8%  (1) 
0 
1.8%  (1) 
7.3%  (4) 
1.8%  (1) 
40%  (22) 





Note.  n = sample; N = total sample; M = mean; SD = standard deviation; DM = diabetes 
mellitus.  Means and SD between continuous variable (age) of the two groups were compared 
using independent samples t-test; frequencies of the nominal variables (gender and DM type) 
were compared using chi-square test of independence. 
aUsing two-sided Fisher’s exact test. 
 
Table 4 provides a comparison of the 1,528 insulin opportunities yielded from the 92 patients.  
The isolation type, the shift during which the administering RN worked, and the time lapse from 
the blood glucose check to the insulin administration time were analyzed.  The double-checking 
group had 740 opportunities while the single-checking group had 788.  Even though these 1,528 
insulin opportunities were yielded from 92 patients, each opportunity was treated as an 
independent event for purposes of analyzing data in Tables 4 and 5. 
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Table 4 
Characteristics of the 1,528 Subcutaneous Insulin Administration and Omission Opportunities 
Variable Double-checking 
group (n = 740) 
Single-checking  
group (n = 788) 
t c2 p Value 
Age of pt, in years 
 
 
M = 68.34 
SD = 18.43 
M = 72.57 
SD = 13.39 
5.118a N/A <.001a 
Gender of pt (n) 
  Male 
  
 
61.1%  (452) 
 
 








DM type of pt (n) 
  Type 1 
  Type 2 
  None 
  None, but on steroids 
  Pre-diabetes 
  Gestational 
  Unknown 
  Unknown, but on steroids 
  Unspecified 
  Unspecified, but on steroids 
 
 
8.5%  (63) 
25.9%  (192) 
0.1%  (1) 
9.2%  (68) 
0.8%  (6) 
0 
10.7%  (79) 
3.4%  (25) 
33.6%  (249) 




3.8%  (30) 
1.6%  (13) 
0 
0.9%  (7) 
6.7%  (53) 
3.2%  (25) 
40.1%  (316) 
2.7%  (21) 
 
N/A --- ---b 
Isolation precaution type of pt (n) 
  Airborne 
  Enteric (C. difficile) 
  Contact 
  Contact and droplet 
  Droplet 
  Not in isolation 
 
 
0.8%  (6) 
3.5%  (26) 
9.5%  (70) 
0 
0.7%  (5) 
85.5%  (633) 
 
0 
7%  (55) 
18.8%  (148) 
0.1%  (1) 
7.2%  (57) 
66.9%  (527) 
N/A 104.1 <.001c 
 
Shift of administering RN (n) 
  Day 
  Night 
   
 
67.3%  (498) 
32.7%  (242) 
 
 
67.6%  (533) 
32.4%  (255) 
N/A .020 .886 
 
Time lapse from BG check to 
insulin administration, in minutes 
Md = 32.54 
SDd = 43.16 
Me = 20.84 
SDe = 29.76 
2.931a N/A .004a  
 
 
Note.  n = sample; N = total sample; pt= patient; M = mean; SD = standard deviation; DM = diabetes 
mellitus; BG = blood glucose. 
aWhen equal variances not assumed. bFisher’s exact test cannot be computed.  cUsing two-sided Fisher’s 
exact test.  dOut of 155 administered (not omitted) opportunities.  eOut of 225 administered (not omitted) 
opportunities.   
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 Differences in characteristics between the two checking groups.  As shown in Table 4, 
between the two groups, there was a significant difference in mean age (t1343= 5.118, p < .001) 
and in mean time lapse from blood glucose (BG) check to insulin administration (t253= 2.931, p 
= .004), even when equal variances are not assumed.  The single-checking group was older than 
the double-checking group, with the average age for the single-checking group being 72.57 
(±13.39), while the average age of the double-checking group was 68.34 (±18.43).  The double-
checking group had a longer time lapse from the BG check to insulin administration, with its 
average time lapse being 32.54 (±43.16) minutes, while the average time lapse of the single-
checking group was 20.84 (±29.76) minutes. This meant that the double-checking group had a 
time lapse that was 11.7 minutes longer than that of the single-checking group.  Additionally, 
there was a significant difference between the isolation types encountered in the two groups, 
with the single-checking group encountering more isolation frequencies than the double-
checking group (c2 [5] = 104.1, p < .001). 
Correlations among the variables.  Table 5 summarizes the results of the Pearson r 
correlation test that was performed to determine if there was a relationship between certain 
sample variables and the likelihood of medication error occurrence.  The likelihood of error 
occurrence was based on predicted probability values (continuous variable) yielded from logistic 
regression.  There was a significant relationship between age and the likelihood of error 
occurring (r = .061, p = .017), although the relationship was weak and could be attributed to 
error, since every age--including outliers--was listed instead of grouped in ranges.  Additionally, 
there was a significant relationship between the shift type and the likelihood of error occurring (r 
= -.052, p = .042).  On the other hand, there was not a significant relationship between the 
checking type and the likelihood of error occurring (r = .002, p = .942).  However, because of the 
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nominal nature of the shift type and check type variables, the interpretation of these correlations 
using a Pearson r correlation may be limited.  Therefore, chi-square tests of independence were 
performed on these nominal variables.  The results will be discussed next. 
Table 5 
 
Correlations of Variables with the Likelihood of Error Occurring 
Variable 
 
Level Coding in SPSS ra p Valuea 
Age Ratio Age in years  .061 .017 
Gender Nominal 1 for male; 2 for female .006 .811 
Shift type Nominal 1 for day; 2 for night  -.052 .042 
Checking type Nominal 1 for single; 2 for double .002 .942 
 
Note.  A total of 1525 opportunities were used to report the Analog of Cook’s influence statistics.  
Also note that all the variables listed, except for age, are at a nominal level of measurement, 
which could limit the interpretation of these correlations.  The likelihood of error occurrence was 
based on predicted probability values (continuous variable) yielded from logistic regression.  
SPSS= Statistical Package for the Social Sciences. 
aBased on Analog of Cook’s influence statistics. 
 
Differences in outcome measures between the day and night shift groups.   
Results from the eMAR task audits, day versus night shift.  In order to more closely 
look at the difference in error rates between the shift groups and error rates, frequencies were 
compared through a chi-square test of independence (Table 6).  The day shift group had 
significantly more “any one error” than the night shift (c2 [1] = 16.057, p < .001).  The day shift 
group also had significantly more “wrong-time” errors than the night shift group (c2 [1] = 
36.718, p < .001).   
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Table 6 
Frequencies of the Outcome Measures Between the Day Shift and Night Shift, eMAR Audits 
Outcome Measure 
 
Day shift (n) 
 
Night shift (n) c2 
 
df p Value 
Any one error? 
      Yes 
      Total (N) 
       
 
 














Administration error  
  Wrong time? 
      Yes 
      Total (N) 
 
  Over-dosed? 
      Yes 
      Total (N) 
 
  
  Under-dosed? 
      Yes 
      Total (N) 
 
 
  Wrong BG charted? 
      Yes 
      Total (N) 
 
  Wrong preparation? 
      Yes 
















































































































      Yes 




















Note.  eMAR: electronic medication administration record; n = sample; N = total sample; BG = 
blood glucose. 
aUsing two-sided Fisher’s exact test.   
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Results from the “Errors Prevented Form” tallies, day versus night shift.   The “Errors 
Prevented Form” (see Appendix D, Figure D1) was made available to Sub-ICU RNs to self-
report prevented errors during the double-checking phase only.  Day shift RNs (shift hours from 
0700-1930) were instructed to use the forms printed in pink cardstock while night shift RNs 
(1900-0730) were instructed to use forms printed in blue cardstock.  The color of form used 
during the 30-minute shift change overlap period depended on which shift the primary RN 
worked.  Table 7 compares outcome measures between the day and night shift.  Note that the 
“wrong preparation prevented” in day shift could have resulted in an under-dosing error of 1 to 8 
units, depending on the algorithm ordered (see Appendix C, Figure C1).  Chi-square tests of 
independence showed that there were no significant differences between the two shifts.   
Table 7 
 
Frequencies of the Outcome Measures PREVENTED Between the Day Shift and Night Shift 




Day shift  
(N = 298) 
Night shift  
(N = 160) 
c2 
 
df p Value 
Inappropriate omission prevented? 













      Yes 
      
 
2  (0.7%) 
 























Wrong preparation prevented? 












No errors prevented? 
      Yes 
 
295  (99%) 
 








Note.  aUsing two-sided Fisher’s exact test.  bThe “Errors Prevented Form” in this instance had 
the comment: “Blood sugar 240 but RN wrote 204 on flowsheet; discovered with double-check.”  
INDEPENDENT DOUBLE-CHECKS AND SUBCUTANEOUS INSULIN          44 
Differences in outcome measures between the single and double-checking groups.  
Table 8 provides a comparison of how often each of the outcome error types occurred during the 
double-checking and the single-checking phases.  Note that no subcutaneous insulin-related 
MIDAS risk management reports and no “Self-Report of Wrong Preparation Error” forms (see 
Appendix D, Figure D3) were filed during either phase of the pilot study.  Although the double-
checking group had more “any one error” (10.9%, n = 81) than the single-checking group (9.3%, 
n = 73), this was not a significant difference (c2 [1] = 1.191, p = .275).  Moreover, between the 
two checking groups, there was no significant difference in the “over-dosed” (p = .207, Fisher’s 
two-sided exact test), “under-dosed” (c2 [1] = .533, p = .465) and “wrong preparation” errors (p 
= 1.000, Fisher’s two-sided exact test).  However, among the administration errors, the double-
checking group had significantly (c2 [1] = 7.635, p = .006) more “wrong-time” errors (33.5%, n 
= 52) than the single-checking group (20.9%, n = 47),   
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Table 8 










df p Value 
Any one error? 
      Yes 
      Total (N) 
       
 
 
















Administration error  
  Wrong time? 
      Yes 
      Total (N) 
 
  Over-dosed? 
      Yes 
      Total (N) 
 
  
  Under-dosed? 
      Yes 
      Total (N) 
 
 
  Wrong BG charted? 
      Yes 
      Total (N) 
 
  Wrong preparation? 
      Yes 























































































































      Yes 



















Note.  eMAR: electronic medication administration record; n = sample; N = total sample; BG = 
blood glucose. 
aUsing two-sided Fisher’s exact test.   
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 Differences in the time lapse (in minutes) among isolation types.  There was a 
significant difference in the length of the time lapse from BG check to insulin administration for 
at least one of the isolation types (F 3, 376= 2.730, p = .044).  A Tukey’s honestly significantly 
difference (HSD) post-hoc test revealed that the significant time difference (p = .043) was 
between the enteric (C. difficile)—which took an average of 12.38 (± 16.016) minutes—and the 
droplet precaution type—which unexpectedly took longer—at an average of 48.10 (± 53.507) 
minutes.  However, when an independent samples t-test was performed to compare the mean 
time lapse between the enteric and droplet isolation types, with equal variances not assumed, 
there was not a significant difference (t9.679= 2.073, p = .066).  These unexpected results could 
be due to the skewness of the data set in these groups, especially of the droplet isolation data set 
that is skewed right (Figure 1).   
 
Figure 1.  Data set boxplots for isolation type and time lapse, where “iso” 2 is the code for 
enteric precautions, 3 is for contact, 5 is for droplet, and 6 is for none; the contact with droplet 
precaution type (coded as “4”) was omitted due to its small sample (n = 1). The labels for outlier 
numbers identify case identification numbers from the whole data set (N = 1,528). 
INDEPENDENT DOUBLE-CHECKS AND SUBCUTANEOUS INSULIN          47 
 Model significance and variance.  Logistic regression tests were performed in order to 
predict the probability of “any error” occurring from the check type, while controlling for other 
predictor variables, such as age, gender, DM type, isolation type, and shift type.  The single 
categorical logistic regression model was significant (c2 [6] = 36.883, p < .001).  However, only 
between 2.4% (Cox & Snell R2) to 5% (Nagelkerke R2) of the variance in the dependent variable 
(i.e., “any one error”) can be explained by the independent variables (i.e., check type, age, 
gender, DM type, isolation type, and shift type), which means that at least 95% of the variation 
was a result of something other than the relationship studied, perhaps of variables not examined 
in the study (Grove, Gray, & Burns, 2015).  The multiple categorical logistic regression was also 
significant (c2 [60] = 167.127, p < .001) though only 10.4% (Cox & Snell R2) to 21.6% 
(Nagelkerke R2) of the variance in the dependent variable (i.e., “any one error”) can be explained 
by the independent variables (i.e., check type, age, gender, DM type, isolation type, and shift 
type).   Therefore, in both cases, it can be concluded that the check type, which was one of the 
independent variables, did not contribute a significant effect to the likelihood that a medication 
error would occur.    
Implementation Observations 
 The most challenging part of the implementation was the preparation period—where the 
PI met with Sub-ICU RNs individually and in small groups to brief them about the pilot 
procedures and obtain their signatures acknowledging their understanding.  Because there were 
about 50 RNs who needed to be seen, it was challenging to meet all of them at the same time, 
requiring multiple visits during the day and night shifts.  When briefed on the correct calculation 
method for insulin when patient parameters fell outside the dosing sliding scale tables, many 
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Sub-ICU RNs verbalized their unawareness about their option to use the algorithm ratios (see 
Appendix C, Figure C1) that were explicitly stated within the eMAR insulin task.   
The pilot project itself was accepted among Sub-ICU RNs with enthusiasm--some of 
them verbalized their curiosity over the end results, especially those who have experienced 
giving subcutaneous insulin without the requirement to perform an IDC prior to administration.  
Some of them verbalized excitement over the temporary permission to single-check.  However, 
there were some RNs who did not initially participate in single-checking (i.e., they were still 
entering other RN’s names, instead of the PI’s, for the co-signature field in the eMAR insulin 
task).  When reminded that they could do so if they decided to participate, some of them 
verbalized having missed the multiple email and early shift “huddle” announcements that the 
single-checking period had started.   
With the Sub-ICU charge RNs’ help, announcements were made on a regular basis to 
remind the staff nurses that the single-checking period had started.  As a result, more Sub-ICU 
RNs participated in single-checking.  However, a few floating RNs also participated, possibly as 
an unintended consequence of these announcements.  This required the PI to exclude those 
insulin opportunities from the sample and immediately communicate with these RNs about their 
ineligibility to participate in those insulin opportunities.  After the end of the single-checking 
period, which was also the end of the pilot study, a Sub-ICU RN continued to single-check, 
which also prompted the PI to immediately communicate to the RN and remind the rest of Sub-
ICU that the pilot study had ended. 
While performing the audits early in the pilot study (during the double-checking phase), 
the PI identified an extraneous variable, that some RNs incorrectly documented the BG within 
the eMAR insulin task.  This prompted the PI to add “Wrong BG charted” to the outcome 
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measures although tracking of this outcome measure was not initially planned.  Moreover, the PI 
realized that there was no automated checkpoint process in place to prevent the wrong multidose 
single patient-use insulin pen from being used on the wrong patient.  The only countermeasure to 
this preparation error was the requirement for nurses to manually affix a patient label on the 
insulin pen upon withdrawing it from the Pyxis automated dispensing medication cabinet; even 
then, the patient label itself was not linked to the insulin pen nor did it have a barcode that was 
recognizable by the eMAR. 
Finally, although the PI initially decided to use the “Errors Prevented Form” (see 
Appendix D, Figure D1) as the main method to track outcome measures during the double-
checking phase, the PI later identified another extraneous variable.  Not all participating Sub-
ICU RNs were completing these forms every time, limiting the interpretation of the “Errors 
Prevented Form” data findings.  “Wrong-time” errors could not be thoroughly tracked, also, 
which was the error most frequently observed in the Modic et al. study (2016).  Additionally, the 
assessment form was designed for two people to complete and hence was not feasible for RNs to 
use during the single-checking phase.  Therefore, in order to use an error assessment method that 
could be consistently implemented during both double-checking and single-checking phases, the 
PI decided to use eMAR chart audits as the main data source. 
Impact of the Project 
The aim of this study was to investigate whether the current practice (of requiring an 
independent double-check [IDC] prior to subcutaneous insulin administration) at the hospital is 
still consistent with the most current evidence.  Because there is limited literature on the 
effectiveness of IDC in reducing subcutaneous insulin-related medication errors, this project may 
further contribute to the developing body of knowledge on this topic and could offer a 
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reproducible model for future studies.  Lessons learned from this project and recommendations 
for future studies will be discussed in the next chapter. 
With the results of this evidence-based practice project, practitioners and hospital 
policymakers where the pilot study was performed can appraise additional evidence and decide if 
an IDC should continue to be required of nurses prior to subcutaneous insulin administration 
with this select patient population.  (Note: Approximately five months after the pilot study 
ended, in late April 2018, the hospital where the study was performed started using its affiliated 
hospitals’ EHR.  This prompted the hospital to allow its RNs to single-check prior to 
administering subcutaneous insulin [U-100] to adult patients, to align with its affiliated hospitals’ 
single-checking policies.)  
Summary 
 This chapter provided details on the results of the pilot study’s double and single-
checking phases.  It explained the type of data that were collected, analyzed, and compared.  
Methods of analysis and their rationales were reviewed and further explained.  Findings were 
presented in tables, figures, and in narrative.  Interpretations of the findings were also postulated. 
More importantly, this chapter answered the first study question: Although there was no 
significant difference in the “any one error” rate between the double-checking and the single-
checking groups (c2 [1] = 1.191, p = .275), the double-checking group had significantly more 
“wrong-time” errors than the single-checking group (c2 [1] = 7.635, p = .006).  This chapter also 
answered the second study question: Although there was no significant relationship between the 
checking type and the likelihood of error occurring (r = .002, p = .942), there was a significant 
negative relationship, between the shift type and the likelihood of error occurring (i.e., there was 
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less likelihood of error occurring in night shift; r = -.052, p = .042).   Chi-square tests revealed 
that the day shift had significantly more “any one error” (c2 [1] = 16.057, p < .001) and “wrong-
time” errors (c2 [1] = 36.718, p < .001) than the night shift.   
Finally, observations from the study’s implementation were discussed.  The impact of the 
project on the agency’s local community was also considered.  The next and final chapter will 
offer possible conclusions drawn from the project, further discuss implications for nursing 
practice, and make future recommendations. 
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Chapter 5 
 Conclusion 
The traditionally supported practice of nurses double checking subcutaneous insulin 
before administration, albeit non-evidence-based, poses a clinical problem by imposing an 
unnecessary demand on nurses’ workload, which places an obstacle to their timely 
administration of subcutaneous insulin.  This may induce financial loss to the hospital due to 
reduced nursing productivity secondary to an inefficient patient care flow process and nurse 
overtime wages.  This may also lead to wrong-time (late) medication administration errors that 
may place patients at risk for hypoglycemia, which is seen in insulin stacking—the practice of 
administering additional doses of insulin before a previous dose of insulin has had its full effect 
(Heise & Meneghini, 2014).  These factors make this issue a priority for health care 
organizations and thus the results of this study have important nursing implications.   
Nursing Implications 
There was no significant difference in the “any one error” rate between the double-
checking and the single-checking groups (c2 [1] = 1.191, p = .275), which implies that the 
significantly longer process of double-checking (t253= 2.931, p = .004)—that took an average of 
11.7 minutes longer than single-checking—did not significantly decrease “any one error” rates.  
The double-checking group showed significantly (c2 [1] = 7.635, p = .006) more “wrong-time” 
errors (33.5%, n = 52) than the single-checking group (20.9%, n = 47).  Furthermore, although 
double-checking was initially theorized by ISMP and TJC to reduce serious medication errors, 
especially over-dosing and wrong-preparation errors (Cohen et al., 1998; The Joint Commission, 
1999), the results of this study showed that there was no significant difference in the “over-
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dosed” (p = .207, Fisher’s two-sided exact test) and “wrong preparation” errors (p = 1.000, 
Fisher’s two-sided exact test) between the double-checking and single-checking groups.  
Because double-checking did not prevent the most prevalent subcutaneous insulin-related error 
type—which was “wrong-time” errors—but instead was significantly associated with it, high 
reliability health care organizations must focus on re-constructing the system to reduce nurses’ 
workload and subcutaneous insulin administration delays, rather than enforcing a time-
consuming verification practice that is not based on current evidence.     
Strengths 
 This study’s findings are consistent with those of a recent similar study (Modic et al., 
2016), most relevant to this project and parts of which were replicated in this study.  The finding 
that there was no significant difference in the “any one error” rate between the double-checking 
and single-checking groups was consistent with the study findings of Modic and colleagues.  
Moreover, “wrong-time” errors were identified to be the most prevalent error in both studies.  
Even though significant differences between the control and experimental groups of this 
project were determined by a p value set at £ .05, the risk of type I “false positive” errors is still 
low when interpreting the significant results that have a p value of < .01, such as the significantly 
longer process of double-checking (t253= 2.931, p = .004) and the more frequent occurrence of 
“wrong-time” errors during double-checking (c2 [1] = 7.635, p = .006).  The risk of type II “false 
negative” errors was also controlled by obtaining a large sample (N = 1,528).  
Limitations 
 Although this study had a large sample, it is not without limitations.  For example, it only 
included high acuity patients in a single unit at an acute care hospital, making the results less 
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generalizable to other settings.  Additionally, because every age—including outliers—was listed 
instead of grouped in ranges, this could limit the interpretation of the significant positive 
relationship found between age and the likelihood of error occurring (r = .061, p = .017).  
Another limitation stems from the logistic regression tests that showed at least 95% of the 
variance (single categorical) and approximately at least 80% of the variance (multiple 
categorical) in the dependent variable (i.e., “any one error”) cannot be explained by the 
independent variables (i.e., check type, age, gender, DM type, isolation type, and shift type).  
This means that the unexplained variance could be due to variables that were not examined in the 
study.  It is worth noting that among the variables omitted in this study, but included in the study 
by Modic et al. (2016), was the nurse license type (registered nurse versus practical nurse). 
Modic and colleagues, hypothesizing that different types of nurses could have had routines that 
led to a higher tendency of errors, collected and controlled for the type of nurse.  Future studies 
may need to explore how to measure and control for nurse demographics, without sacrificing 
anonymity and confidentiality principles.   
Lastly, completion of the “Errors Prevented Form” during the double-checking phase 
may have contributed to the time lapse between BG check to insulin administration.  Completion 
of the form was an added step to the established double-checking process at the unit where the 
study took place.  Future replication studies need to take into consideration the aforementioned 
limitations of this study and make every attempt to control for both extraneous and confounding 
variables.  
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Recommendations for the Future 
Although there was not a significant relationship between the checking type and the 
likelihood of error (r = .002, p = .942), the results showed that there was a significant negative 
correlation between the shift type and the likelihood of error occurring—that there was less 
likelihood of error in night shift than the day shift (r = -.052, p = .042).   The day shift had 
significantly more “any one error” (c2 [1] = 16.057, p < .001) and “wrong-time” errors (c2 [1] = 
36.718, p < .001) than the night shift.  Further study is recommended to explore factors that may 
contribute to the higher likelihood of error during the day shift.   
Additionally, although Table 7 shows that there were no significant differences in the 
error types (measured through the “Errors Prevented Form” tallies) between the two shifts, note 
that the “wrong preparation prevented” in day shift associated with the wrong blood glucose 
(BG) charted could have resulted in an under-dosing error of 1 to 8 units, depending on the 
algorithm ordered (see Appendix C, Figure C1).  Moreover, even though there was not a 
significant difference in the “wrong BG charted” error in between the double-checking and 
single-checking groups (c2 [1] = .001, p = .976), innovative solutions must be explored to 
prevent nurses from administering the wrong dose based on the wrong BG charted.  For 
example, Hamilton and Morris (2014) built an effective solution to reduce medication errors 
related to continuous heparin infusion dosing at the Cleveland Clinic by developing an 
automated heparin dose calculator within the electronic health record (EHR).   
It was also determined that there was no automated checkpoint process in place to 
prevent the wrong multidose single-use insulin pen from being used on the wrong patient, apart 
from requiring a manual check of the nurse-affixed patient label.  Such a preparation error could 
expose patients to bloodborne infections.  Therefore, further investigation is needed to determine 
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what automated checkpoint processes are in place at other high-reliability organizations (HRO) 
to prevent this type of preparation error. 
With the projected rise of diabetes prevalence and subsequent increase in the use of 
subcutaneous insulin in the acute care setting over the next few decades, health care 
organizations are encouraged to take a systems approach in mitigating medication errors.  This 
can be accomplished by shifting focus from enforcing time-consuming verification processes 
prior to performing high-frequency tasks, such as subcutaneous insulin administration, to 
maximizing system barriers that minimize nurses’ error-provoking conditions—that is, by 
reducing the time pressure that heavily weighs on nurses’ workload.  These proposed 
countermeasures are based on the premise that “though we cannot change the human condition, 
we can change the conditions under which humans work” (Reason, 2000, p. 768).   
Hospital policymakers need to be aware of the limitations documented in the literature 
related to independent double-checking.  In an effort to progress the institution toward a safe, 
high-reliability organization (HRO), organizations must recognize that though “human 
variability is a force to harness in averting errors” leaders must also “work hard to focus that 
variability and…constantly [be] preoccupied with the possibility of failure” (Reason, 2000).  
HROs need to consider accomplishing this through a systems approach where those at the blunt-
end of errors (i.e., those in managerial or policy-making positions) are aware of the need to 
modify the conditions under which those at the sharp-end work (i.e., frontline workers).  A 
hospital organization that seeks to be an HRO must recognize that to err is naturally human and 
that with a systems approach, rather than relying on double-checking techniques that are 
contingent on its fallible front-line nurses, minimizing the factors that could provoke their errors 
would be a better approach to averting them.  
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Appendix A 
The Iowa Model 
 
Figure A1.  The Iowa Model (1998) in detail.  Used/Reprinted with permission from the 
University of Iowa Hospitals and Clinics. Copyright 1998.  For permission to use or reproduce 
the model, please contact the University of Iowa Hospitals and Clinics at (319) 384-9098.  
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Appendix B 
IRB Approval Documents 
The approved study protocol (dated October 25, 2017), with hospital information censored 
(substitute the word ‘hospital’), may be accessed through clicking or copying/pasting this link 
onto the browser’s address bar: https://www.dropbox.com/s/able1xog45d3nwh/Protocol version 
dated 25Oct2017 privacy mode.tiff?dl=0  
 
Figure B1.  The study hospital’s Institutional Review Board (IRB) approval letter. 
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Appendix C 
Pre-pilot Briefing Sessions 
Sub-ICU RNs were asked to calculate the appropriate subcutaneous insulin aspart (Novolog®) 
dose in three scenarios, with these patient parameters:   
 
(1) Patient ate 130 grams of carbohydrates (CHO) for dinner, had blood glucose (BG) of 90 
mg/dL before dinner, and had algorithm A ordered for CHO coverage.  (Answer: 6 units) 
 
(2) Patient ate 125 grams of carbohydrates (CHO) for dinner, had BG of 90 mg/dL before dinner, 
and had algorithm A ordered for CHO coverage.  (Answer: 7 units) 
 
(3) Patient did not eat lunch due to a nothing by mouth (NPO) order but is receiving 
methylprednisolone (Solu-medrol) intravenously.  His noon BG was 410 mg/dL; second recheck 
yielded 405 mg/dL.  Algorithm B was ordered for correction.  (Answer: 13 units, instead of the 
otherwise correct 14 units.  The hospital’s diabetes educator instructed not to exceed the 
maximum number of units when patient parameters are outside the yellow-and-white correction 
dosing table.  For example, though the BG were more than 400 mg/dL, the RN should not give 
more than 9 units [algorithm A], 13 units [algorithm B], 26 units [algorithm C], or 52 units 
[algorithm D], unless the doctor orders otherwise.) 
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Figure C1.  A pre-printed copy of the hospital’s subcutaneous insulin sliding scale tables and 
algorithm ratios that Sub-ICU RNs referred to during the briefing sessions.  These tables and 
ratios were available for immediate viewing within the insulin eMAR task window.   
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Appendix D 
Tools Used for the Pilot’s Data Collection 
Access the four-page pilot manual through this link (if hyperlink does not work, copy and paste 
the link onto web browser address bar): https://www.dropbox.com/s/sqx87cvfamolcod/Pilot 
MANUAL for RNs privacy mode.tiff?dl=0 
 
 
Figure D1.  A blank “Errors Prevented” form (9 cm x 14 cm), that was made available to the 
Sub-ICU RNs to report prevented errors during the double-checking phase, with the PI’s contact 
number censored. 
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Figure D2.  The locked red drop box for the preprinted “Errors Prevented” forms during the 
double-checking phase and the “Self-Report of Wrong Preparation Error” forms during the 
single-checking phase. 
 
Figure D3.  A blank “Self-Report of Wrong Preparation Error” form that was available for the 
Sub-ICU RN to report wrong preparation errors during the single-checking phase of the pilot 
study. 
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Figure D4.  A template of Worksheet 1 stored in the PI’s hospital IT-generated and secured 
computer directory.  VAN = visit account number; DM = diabetes mellitus; iso = isolation 
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Appendix E 
Certificates from Human Subjects Protection Training 
 
Figure E1.  Certificate proof of the principal investigator’s (PI) completion of the “Protecting 
Human Research Participants” course provided by the National Institutes of Health (NIH). 
 
 
Figure E2.  Certificate proof of the principal investigator’s (PI) completion of the “Biomedical  
Research” course provided by the Collaborative Institutional Training Initiative (CITI) program. 
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Figure E3.  Certificate proof of the principal investigator’s (PI) completion of the “Conflicts of  
Interest” course provided by the Collaborative Institutional Training Initiative (CITI) program. 
 
 
Figure E4.  Certificate proof of the principal investigator’s (PI) completion of the “Good 
Clinical Practice” course provided by the Collaborative Institutional Training Initiative (CITI) 
program. 
